BRIEF-Exicure Partners With GPCR Therapeutics To Fuel New Growth In Biotech
ReutersDec 27, 2024 1:12 AM
Dec 26 (Reuters) - Exicure Inc XCUR.O:
EXICURE, INC. PARTNERS WITH GPCR THERAPEUTICS TO FUEL NEW GROWTH IN BIOTECH
Source text: ID:nBw1xXcfda
Further company coverage: XCUR.O
((reuters.briefs@thomsonreuters.com;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
What Is the Debasement Trade? Markets Have Picked Three Winners and One Loser
TradingKey - Since October, as the U.S. dollar, yen, and euro weaken, while gold, silver, and Bitcoin surge to new highs, Wall Street has embraced a powerful new investment narrative: the “Debasement Trade.” This term captures the extraordinary shift of capital from traditional currencies andTradingKey
2 hours ago
UK August GDP: Economy & Assets—Set to Collapse?
TradingKey - The UK is scheduled to release its August GDP figures on 16 October, with the market widely anticipating a 0.1% month-on-month increase in real GDP (Figure 1). If this expectation is fulfilled, it will represent the UK economy’s third consecutive month of recovery, following two straighTradingKey
23 hours ago
U.S. Banks Q3 Earnings Preview: Big 5 Banks See Double-Digit EPS Growth, Investment Banking Hits 4-Year High
TradingKey - The 2025 U.S. earnings season kicks off this week with results from major banks. Amid elevated investor sentiment and the Trump administration pushing for deregulation, analysts expect another strong quarter for the banking sector — driven by booming trading activity and a resurgenceTradingKey
Mon, Oct 13
FOMC October Meeting Minutes: How Should Investors Respond?
In the context of the U.S. government shutdown and a period of limited economic data, the Federal Reserve’s release of its latest monetary policy meeting minutes and officials’ statements on 8 October will be particularly significant.TradingKey
Tue, Oct 7
ASML Q2 FY2025 Earnings Review: Strong Growth and High-NA EUV Breakthrough Shadowed by 2026 Uncertainty
ASML Holding N.V. (NASDAQ: ASML) released its Q2 FY2025 earnings on July 16, 2025, exceeding market expectations with robust net sales and net bookings, though the stock fell around 10% due to cautious guidance for 2026 amid geopolitical uncertainties.TradingKey
Mon, Jul 14
